Case control studies have reported associations between specific HLA class II antigens and idiopathic dilated cardiomyopathy (DCM), suggesting that genetically regulated immune response factors may be involved in the pathogenesis ofthis disease. In this study, families with DCM were used to test the hypothesis that a heritable gene defect in the HLA region is the primary genetic determinant for a subset of cases. Twelve families with DCM were identified. By formal segregation analysis, the inheritance of the disease was most consistent with an autosomal dominant gene defect with incomplete penetrance. Genotyping was performed with five highly polymorphic linked dinucleotide repeat markers that span the HLA locus. Linkage analysis was used to determine whether or not these genetic markers cosegregated with the disease phenotype. Genetic linkage between the disease phenotype and a 21 cM region spanning the HLA was excluded (lod score < -2) in at least 60% of our families. These results indicate that a gene defect in the HLA locus region is not the primary genetic determinant of DCM in a series of familial cases. However, our data do not exclude the possibility that HLA regulated immune response factors may have a modifying effect on disease penetrance and expression.
Results Twelve DCM families were tested with each of the five markers spanning the HLA locus. Based on the age dependent penetrance model and two point analyses, all five markers spanning the HLA locus had lod scores <-2 at a recombination fraction of zero (table), effectively excluding the HLA locus as the primary gene defect in our families. There was no evidence of genetic heterogeneity for any of the five markers, with the smallest p value of 0-17 for the marker D6S276, based on the admixture test using the HOMOG program.22
To combine the linkage information from the five markers, we performed multipoint linkage analyses. For this, only affected subjects were included. Multipoint analysis allowed exclusion of a 51 cM region spanning the HLA region (fig 2) . Again, there was no evidence of genetic heterogeneity using multipoint lod scores for the admixture test (p = 1 -0). However, because we had only 12 Haldane map distance (cM) <-2 at a recombination fraction of zero for at least one of the markers. Linkage analysis was performed using five polymorphic markers spanning 9 cM and including the HLA locus on chromosome 6p2l.3. However, the HLA locus could be excluded based on the total lod score for all 12 pedigrees using two point analyses; a minimum distance of 16 cM could be excluded using multipoint analyses with all families potentially linked, and a minimum distance of 0-5 cM excluded when no less than 60% of DCM is attributable to linkage with that region. We recognise that the power of such analyses is limited by the relatively small number of pedigrees and the small sizes and limited informativeness of the pedigrees. Although it is possible that a genetically distinct subset of these families could be linked to the HIA region, this subset is probably less than 60% of our DCM families. Lod scores were negative for nine of 12 DCM families at recombination frequencies of 0-20% for D6S273, the marker that is most closely linked to the HLA class II DR locus. This study provides additional support for the conclusions by Krajinovic et al'0 and
Carlquist et al8 that DCM cannot be explained solely by the presence or absence of a single HIA allele, by providing evidence for exclusion of a primary gene defect at the HLA locus in a series of families with DCM. Also in agreement with their conclusion, this does not exclude the possibility that HIA regulated immune response factors could have a modifying effect on disease penetrance and expression. This study provides evidence against an unidentified gene in the HIA locus region as the primary determinant of DCM in our families, and thus provides support for the possible modifying effects of HLA genes on the disease.
